Cytoxan Lyophilized Interactions
There are 398 drugs known to interact with Cytoxan Lyophilized (cyclophosphamide), along with 6 disease interactions. Of the total drug interactions, 59 are major, 310 are moderate, and 29 are minor.
- View all 398 medications that may interact with Cytoxan Lyophilized
- View Cytoxan Lyophilized disease interactions (6)
Most frequently checked interactions
View interaction reports for Cytoxan Lyophilized (cyclophosphamide) and the medicines listed below.
- Actemra (tocilizumab)
- Adriamycin (doxorubicin)
- Avastin (bevacizumab)
- bleomycin
- Blincyto (blinatumomab)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Cosentyx (secukinumab)
- Cytovene (ganciclovir)
- Depakote Sprinkles (divalproex sodium)
- Etopophos (etoposide)
- Fludara (fludarabine)
- fluorouracil
- Hycamtin (topotecan)
- Intelence (etravirine)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Leukeran (chlorambucil)
- Neoral (cyclosporine)
- Norvir (ritonavir)
- Novantrone (mitoxantrone)
- Nydrazid (isoniazid)
- Oncovin (vincristine)
- Paraplatin (carboplatin)
- prednisone
- Procysbi (cysteamine)
- Promacta (eltrombopag)
- Pulmozyme (dornase alfa)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Thalomid (thalidomide)
Cytoxan Lyophilized disease interactions
There are 6 disease interactions with Cytoxan Lyophilized (cyclophosphamide) which include:
- myelosuppression
- urinary tract obstruction
- cardiac disease/cardiotoxicity
- hepatic dysfunction
- pulmonary impairment
- renal dysfunction
More about Cytoxan Lyophilized (cyclophosphamide)
- Cytoxan Lyophilized consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.